Topos Bio Emerges from Stealth to Tackle Disordered Proteins with $10.5M and Frontier AI
What You Ought to Know – Topos Bio has emerged from stealth with $10.5M in seed ...
Read more
Tag: Bio
Converge Bio Lands $25M to Replace Trial-and-Error Drug Discovery
Converge Bio Workforce What You Ought to Know – Converge Bio has introduced a $25M Sequence ...
Read more
Caravel Bio Wins $7.8M NSF Grant to Pioneer Next-Generation Protein Engineering
What You Ought to Know: – Caravel Bio, the primary joint platform for protein discovery and supply ...
Read more
Weave Bio Raises $20M to Scale AI-Native Regulatory Automation Platform
What You Ought to Know: – Weave Bio, a pioneer in AI-native regulatory automation administration options ...
Read more
Revalia Bio Launches ‘Human Data Trials’ with $14.5M to Transform Drug Development
What You Ought to Know: – Revalia Bio Inc., a brand new pre-clinical analysis firm secures ...
Read more
Ginkgo, Tangible & Inductive Bio Launch AI-Powered Lab-in-the-Loop Drug Discovery
What You Ought to Know: – Ginkgo Bioworks has introduced a brand new strategic partnership with ...
Read more
Mission Bio Unveils Industry-First Single-Cell Genotype and Targeted Gene Expression Solution –
What You Ought to Know: – Mission Bio, a pacesetter in single-cell multiomics options for precision drugs, ...
Read more
Flatiron Health, Massive Bio Partner to Optimize Clinical Trial Enrollment
What You Ought to Know: – Flatiron Health, a healthtech firm targeted on reworking medical analysis ...
Read more
Promise Bio Secures $8.3M for Auto-Immune Precision Medicine Platform –
What You Ought to Know: – Promise Bio, a startup remodeling immune-mediated illness therapy with superior precision ...
Read more
Converge Bio Raises $5.5M to Accelerate Drug Discovery with GenAI –
What You Ought to Know: – Converge Bio, a generative AI platform for accelerated drug discovery and ...
Read more
